These CD8+ TILs express CD103 (integrin alpha E), which is involved in tissue retention, and upregulate CD39 (ectonucleotidase) due to, e.g., continuous activation, which suggests that they exert their effector functions while steadily residing in the tumor as TRM cells. The gene discussed is ENTPD1; the disease is neoplasm.